EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation

Xudong Wang, Tianxi Wang, Enton Lam, David Alvarez, Ye Sun iD

International Journal of Molecular Sciences · 28.07.2023 · 24 (15) · 12090

DOI: 10.3390/ijms241512090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.07.2023. Verfasst von Xudong Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA 02115, USA. Hauptthemen laut MEDLINE: Eye Diseases, Retinal Diseases, Diabetic Retinopathy. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 377 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NEI NIH HHS, NIH HHS, National Institutes of Health/National Eye Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The eye is an immune privileged tissue that insulates the visual system from local and systemic immune provocation to preserve homeostatic functions of highly specialized retinal neural cells. If immune privilege is breached, immune stimuli will invade the eye and subsequently trigger acute inflammatory responses. Local resident microglia become active and release numerous immunological factors to protect the integrity of retinal neural cells. Although acute inflammatory responses are necessary to control and eradicate insults to the eye, chronic inflammation can cause retinal tissue damage and cell dysfunction, leading to ocular disease and vision loss. In this review, we summarized features of immune privilege in the retina and the key inflammatory responses, factors, and intracellular pathways activated when retinal immune privilege fails, as well as a highlight of the recent clinical and research advances in ocular immunity and ocular vascular diseases including retinopathy of prematurity, age-related macular degeneration, and diabetic retinopathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye DiseasesRetinal DiseasesDiabetic RetinopathyInfant, NewbornHumansImmune PrivilegeRetinaInflammation

Stichwörter der Autor:innen

age-related macular degenerationdiabetic retinopathyimmune privilegeinflammationretinaretinopathy of prematurity

Autor:innen und Institutionen

  • Department of Ophthalmology, Harvard Medical School, Boston Children's Hospital, Boston, MA 02115, USA.
  • Department of Immunology, Harvard Medical School, Boston, MA 02115, USA.

ORCID-Profile: Ye Sun

Förderung

  • NEI NIH HHS
  • NIH HHS
  • National Institutes of Health/National Eye Institute
  • BrightFocus Foundation and American Health Assistance Foundation (AHAF)
  • Boston Children’s Hospital Pilot Grant
  • Children’s Hospital Ophthalmology Foundation
  • Knights Templar Eye Foundation

Zitieren

APA

Wang, X., Wang, T., Lam, E., Alvarez, D., & Sun, Y. (2023). Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation. International Journal of Molecular Sciences, 24(15), 12090. https://doi.org/10.3390/ijms241512090

Vancouver

Wang X, Wang T, Lam E, Alvarez D, Sun Y. Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation. International Journal of Molecular Sciences. 2023;24(15):12090. doi:10.3390/ijms241512090

BibTeX
@article{Wang2023,
  author = {Wang, Xudong and Wang, Tianxi and Lam, Enton and Alvarez, David and Sun, Ye},
  title = {Ocular Vascular Diseases: From Retinal Immune Privilege to Inflammation},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  volume = {24},
  number = {15},
  pages = {12090},
  doi = {10.3390/ijms241512090}
}
Kostenlos starten →